HSBC Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.8M | Buy |
211,100
+138,000
| +189% | +$8.04M | 0.01% | 863 |
|
|
2025
Q4 | $3.96M | Buy |
73,100
+27,500
| +60% | +$1.32M | ﹤0.01% | 1302 |
|
|
2025
Q3 | $2.07M | Hold |
45,600
| – | – | ﹤0.01% | 1485 |
|
|
2025
Q2 | $2.12M | Sell |
45,600
-50,000
| -52% | -$2.45M | ﹤0.01% | 1468 |
|
|
2025
Q1 | $5.81M | Sell |
95,600
-22,000
| -19% | -$1.28M | ﹤0.01% | 1070 |
|
|
2024
Q4 | $6.62M | Sell |
117,600
-250,700
| -68% | -$14M | ﹤0.01% | 1045 |
|
|
2024
Q3 | $18.9M | Buy |
368,300
+198,300
| +117% | +$9.3M | 0.01% | 736 |
|
|
2024
Q2 | $7.15M | Buy |
+170,000
| New | +$7.61M | ﹤0.01% | 952 |
|
|
2024
Q1 | – | Sell |
-50,100
| Closed | -$2.57M | – | 3060 |
|
|
2023
Q4 | $2.57M | Buy |
50,100
+10,100
| +25% | +$530K | ﹤0.01% | 1391 |
|
|
2023
Q3 | $2.32M | Sell |
40,000
-125,500
| -76% | -$7.69M | ﹤0.01% | 1376 |
|
|
2023
Q2 | $10.6M | Buy |
165,500
+117,300
| +243% | +$7.87M | 0.01% | 798 |
|
|
2023
Q1 | $3.34M | Sell |
48,200
-135,600
| -74% | -$9.56M | ﹤0.01% | 1298 |
|
|
2022
Q4 | $13.1M | Buy |
183,800
+68,400
| +59% | +$5.16M | 0.02% | 815 |
|
|
2022
Q3 | $8.29M | Hold |
115,400
| – | – | 0.01% | 969 |
|
|
2022
Q2 | $8.93M | Buy |
115,400
+35,000
| +44% | +$2.67M | 0.01% | 958 |
|
|
2022
Q1 | $5.9M | Buy |
+80,400
| New | +$5.4M | 0.01% | 1126 |
|
|
2021
Q2 | – | Sell |
-2,800
| Closed | -$178K | – | 2935 |
|
|
2021
Q1 | $178K | Sell |
2,800
-1,700
| -38% | -$106K | ﹤0.01% | 2566 |
|
|
2020
Q4 | $279K | Hold |
4,500
| – | – | ﹤0.01% | 2616 |
|
|
2020
Q3 | $271K | Hold |
4,500
| – | – | ﹤0.01% | 2311 |
|
|
2020
Q2 | $264K | Sell |
4,500
-5,500
| -55% | -$329K | ﹤0.01% | 2192 |
|
|
2020
Q1 | $557K | Hold |
10,000
| – | – | ﹤0.01% | 1732 |
|
|
2019
Q4 | $639K | Sell |
10,000
-109,000
| -92% | -$6.24M | ﹤0.01% | 2092 |
|
|
2019
Q3 | $6.03M | Buy |
119,000
+92,400
| +347% | +$4.34M | 0.01% | 1098 |
|
|
2019
Q2 | $1.21M | Buy |
26,600
+11,900
| +81% | +$554K | ﹤0.01% | 1707 |
|
|
2019
Q1 | $701K | Sell |
14,700
-85,700
| -85% | -$4.27M | ﹤0.01% | 1981 |
|
|
2018
Q4 | $5.22M | Sell |
100,400
-101,100
| -50% | -$5.43M | 0.01% | 1091 |
|
|
2018
Q3 | $12.5M | Buy |
201,500
+113,100
| +128% | +$6.71M | 0.02% | 759 |
|
|
2018
Q2 | $4.89M | Sell |
88,400
-120,500
| -58% | -$6.51M | 0.01% | 1143 |
|
|
2018
Q1 | $13.2M | Buy |
+208,900
| New | +$13.4M | 0.02% | 714 |
|
|
2017
Q4 | – | Sell |
-155,800
| Closed | -$9.93M | – | 2068 |
|
|
2017
Q3 | $9.93M | Sell |
155,800
-216,500
| -58% | -$12.6M | 0.02% | 801 |
|
|
2017
Q2 | $20.7M | Buy |
372,300
+168,500
| +83% | +$9.17M | 0.04% | 499 |
|
|
2017
Q1 | $11.1M | Buy |
203,800
+72,500
| +55% | +$3.98M | 0.02% | 677 |
|
|
2016
Q4 | $7.67M | Sell |
131,300
-523,600
| -80% | -$28.6M | 0.02% | 809 |
|
|
2016
Q3 | $35.3M | Buy |
654,900
+517,800
| +378% | +$33.3M | 0.09% | 257 |
|
|
2016
Q2 | $10.1M | Buy |
137,100
+115,900
| +547% | +$8.19M | 0.03% | 652 |
|
|
2016
Q1 | $1.35M | Sell |
21,200
-108,300
| -84% | -$6.83M | ﹤0.01% | 1246 |
|
|
2015
Q4 | $8.91M | Buy |
+129,500
| New | +$8.56M | 0.02% | 732 |
|
|
2015
Q2 | – | Sell |
-60,400
| Closed | -$3.9M | – | 2083 |
|
|
2015
Q1 | $3.9M | Sell |
60,400
-111,800
| -65% | -$7M | 0.01% | 990 |
|
|
2014
Q4 | $10.2M | Buy |
172,200
+73,500
| +74% | +$4.15M | 0.02% | 665 |
|
|
2014
Q3 | $5.05M | Buy |
98,700
+37,200
| +60% | +$1.86M | 0.01% | 870 |
|
|
2014
Q2 | $2.98M | Buy |
61,500
+58,800
| +2,178% | +$2.9M | 0.01% | 1009 |
|
|
2014
Q1 | $140K | Buy |
+2,700
| New | +$144K | ﹤0.01% | 1671 |
|
|
2013
Q4 | – | Sell |
-10,500
| Closed | -$486K | – | 1695 |
|
|
2013
Q3 | $486K | Buy |
+10,500
| New | +$461K | ﹤0.01% | 1392 |
|
Other funds holding BMY
VCM
VPM
HSBC Holdings's BMY Position: Q1 2026 in Review
HSBC Holdings reduced its Bristol-Myers Squibb (BMY) stake by 25% in Q1 2026, selling an estimated $93.5M and leaving 4,821,508 shares worth $292M. The position accounts for 0.15% of the portfolio, ranked #120.
HSBC Holdings first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $425M in Q4 2020. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- HSBC Holdings held 4,821,508 shares of Bristol-Myers Squibb worth $292M as of Q1 2026.
- HSBC Holdings sold 1,603,207 Bristol-Myers Squibb shares in Q1 2026, an estimated $93.5M.
- Bristol-Myers Squibb made up 0.15% of HSBC Holdings's portfolio in Q1 2026, its #120 holding.
- HSBC Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Bristol-Myers Squibb position peaked at $425M in Q4 2020.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.